Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL), 3.75 mg versus placebo, in the treatment of pain associated with endometriosis was assessed in a randomized, double-blind, multicenter study involving 52 patients. Dysmenorrhea, pelvic pain, and pelvic tenderness all responded significantly to LA treatment in comparison with placebo. Menses were suppressed in all of the LA patients. Estradiol decreased significantly to menopausal levels in the LA group. There were small to moderate changes in a variety of laboratory parameters, but these were not clinically significant. The most common adverse event was vasodilatation, occurring significantly more frequently in the LA group. Lupron depot was shown to be safe and effective in inducing a hormonal and menstrual suppression in patients with endometriosis, resulting in alleviation of pain symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several trials have shown that GnRH-a improved endometriosis-associated pain [163–166]”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [165]
In the citing paper
“However, six RCTs have already demonstrated that various treatments used for the relief of pain in women with symptomatic endometriosis are far superior to placebo (Telimaa et al., 1987;Dlugi et al., 1990;Fedele et al., 1993;Bergqvist et al., 1998;Harada et al., 2008;Strowitzki et al., 2010b).”
From “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis (2011) · cites this paper as Dlugi et al., 1990
Citations
Cites
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
Henzl, M. R., Corson, S. L., Moghissi, K., Buttram, V. C., Berqvist, C., & Jacobson, J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180805 · Cited by 361
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
Biberoglu, K. O., & Behrman, S. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90478-6 · Cited by 267
MELDRUM, D. R., CHANG, R. J., LU, J., VALE, W., RIVIER, J., & JUDD, H. L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-5-1081 · Cited by 248
SOME ATHEROGENIC CONCOMITANTS OF MENOPAUSE: THE FRAMINGHAM STUDY
HJORTLAND, M. C., MCNAMARA, P. M., & KANNEL, W. B. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112228 · Cited by 242
Lemay, A., Maheux, R., Faure, N., Jean, C., & Fazekas, A. T. A. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47899-4 · Cited by 209
The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone Metabolism
JOHANSEN, J. S., RIIS, B. J., HASSAGER, C., MOEN, M., JACOBSON, J., & CHRISTIANSEN, C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-701 · Cited by 189
Friedman, A. J., Harrison-Atlas, D., Barbieri, R. L., Benacerraf, B., Gleason, R., & Schiff, I. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60486-7 · Cited by 163
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist.
Steingold, K. A., Cedars, M. I., Lu, J. K. H., Randle, D., Judd, H. L., & Meldrum, D. R. (1987) · PubMed · Cited by 131
Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)
Schriock, E. D., Monroe, S. E., Henzl, M. R., & Jaffe, R. B. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48970-3 · Cited by 110
Cited by
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Olive, D. L., & Schwartz, L. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282407 · Cited by 675
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
Liu, R., Luo, C., Pang, Z., Zhang, J., Ruan, S., Wu, M., Wang, L., Sun, T., Li, N., Han, L., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.05.032 · Cited by 516
Metadata
- Authors
- Dlugi, A. M., Miller, J. D., & Knittle, J.
- Affiliations
- North Park University (US)
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 1990-09
- Volume
- 54
- Issue
- 3
- Pages
- 419-427
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2414416208
- Cited by
- 279
- References
- 16
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 7 · 2013: 7 · 2012: 4
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 11591 d)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- leuprolide, endometriosis, dysmenorrhea, pelvic pain, menstrual suppression, estradiol suppression, vasodilation, adverse events, analgesia
- MeSH terms
- Adult, Antineoplastic Agents, Delayed-Action Preparations, Double-Blind Method, Endometriosis, Female, Follow-Up Studies, Humans, Gonadotropin-Releasing Hormone, Pain, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. https://app.cochat.ai/papers/10.1016/s0015-0282(16)53755-8
- The paper
- Dlugi, A. M., Miller, J. D., & Knittle, J. (1990). Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(16)53755-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.